Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion type Assertion NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_head.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion description "[Moreover, type 1 diabetes reversal in preclinical models is accompanied by the selective expansion of CD4(+)Foxp3(+) T regulatory (Treg) cells, which are fundamental for the long-term maintenance of anti-CD3-mediated tolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_provenance.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion evidence source_evidence_literature NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_provenance.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion SIO_000772 25646305 NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_provenance.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion wasDerivedFrom befree-2016 NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_provenance.
- NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_assertion wasGeneratedBy ECO_0000203 NP1260513.RAkTlVJO0aasu6QiX8vwN2qTDTIfh2F13Nu8YjWY2I3UE130_provenance.